Aktis Oncology, Inc. (AKTS) vs HealthStream, Inc. (HSTM)
A side-by-side comparison of Aktis Oncology, Inc. and HealthStream, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AKTS
Aktis Oncology, Inc.
$18.16HealthcareDelayed quote: Oct 6, 2026, 2:20 PM EDT
HSTM
HealthStream, Inc.
$31.25HealthcareDelayed quote: Oct 6, 2026, 2:20 PM EDT
Total return — AKTS vs HSTM
growth of $100 · dividends reinvested · last 1yAKTS -17.3% (-17.3%/yr)HSTM +43.3% (+43.3%/yr)HSTM compounded faster over this window
AKTS HSTM
AKTS vs HSTM: by the numbers
- •AKTS is the larger company ($970M vs $913M market cap).
- •HSTM is profitable (6.60% net margin) while AKTS runs a net loss (-727.04%).
- •HSTM pays a dividend (0.43% yield), while AKTS has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | AKTS | HSTM |
|---|---|---|
| P/E ratio | N/A | 43.68 |
| Forward P/E | N/A | 42.34 |
| PEG ratio | N/A | 6.47 |
| P/S ratio | 96.42 | 2.84 |
| P/B ratio | 2.00 | 2.56 |
| EV / EBITDA | N/A | 12.52 |
| FCF yield | N/A | 5.35% |
Profitability
| Metric | AKTS | HSTM |
|---|---|---|
| Gross margin | 100.00% | 65.08% |
| Operating margin | -1149.52% | 8.04% |
| Net margin | -727.04% | 6.60% |
| ROE | -15.09% | 5.94% |
| ROIC | -16.54% | 4.96% |
Dividends
| Metric | AKTS | HSTM |
|---|---|---|
| Dividend yield | N/A | 0.43% |
| Payout ratio | N/A | 19.01% |
Growth (annualized)
| Metric | AKTS | HSTM |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 5.05% |
| EPS CAGR (5Y) | N/A | 6.75% |
| FCF CAGR (5Y) | N/A | 2.33% |
| Total return CAGR (5Y) | N/A | 2.34% |
Frequently asked
- Does AKTS or HSTM pay a bigger dividend?
- HSTM pays a dividend (0.43% yield), while AKTS has no payments in the available dividend history.
- Is AKTS or HSTM more profitable?
- HSTM runs the higher net margin — AKTS at -727.04% versus HSTM at 6.60%.
Go deeper
Dig into the metrics
HealthStream P/E ratioHealthStream dividend yieldAktis Oncology ROEHealthStream ROEAktis Oncology operating marginHealthStream operating marginAktis Oncology revenue growthHealthStream revenue growthAktis Oncology free cash flowHealthStream free cash flow
Aktis Oncology & HealthStream appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.